Dyne Therapeutics Shares Surge Following Positive Clinical Results for Duchenne Muscular Dystrophy Treatment
Investors flocked to Dyne Therapeutics this week as the clinical-stage biotechnology firm reported significant progress in its ongoing efforts to treat rare
by 
Josh Weiner
Josh Weiner